COVID research in space

The first COVID-19 drug research in space started operations in the European commercial ICE-Cubes facility in December. By examining this medicine in microgravity, researcher aim to better understand how Remdesivir interacts with its delivery substance cyclodextrin so that the drug’s efficiency can be improved. This commercial research from Hungarian companies was installed next to other commercial cube experiments that continued to run in the facility, these include an art project from the International Space University, a test of how standard consumer equipment handles the radiation found in space, and an ESA test of cyber-security in space.